Showing results (351-360 of 427) with videos related to
Sort By:
Pageof 43
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
miR-21-5p promotes NASH-related hepatocarcinogenesisPedro M Rodrigues, Marta B Afonso, André L Simão, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targetsAlvaro Santos-Laso, Laura Izquierdo-Sanchez, Pedro M Rodrigues, et al.Lancet Regional Health. Americas|December 10, 2024
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomesLeonardo G da Fonseca, Laura Izquierdo-Sanchez, Pedro H Hashizume, et al.Hepatology Communications|August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.Ebiomedicine|November 5, 2021
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinomaMonika Lewinska, Alvaro Santos-Laso, Enara Arretxe, et al.Hepatology (Baltimore, Md.)|September 19, 2017
MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activationOihane Erice, Patricia Munoz-Garrido, Javier Vaquero, et al.JAMA Dermatology|June 15, 2022
Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus StudyEric Xia, Jane Han, Adam Faletsky, et al.Journal of Hepatology|April 22, 2021
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targetedAdrián Vallejo, Oihane Erice, Rodrigo Entrialgo-Cadierno, et al.Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.Pageof 43